Neimeth appoints Gerald Ijeoma Oputa as acting MD/CEO

Neimeth International Pharmaceuticals Plc has notified the Nigerian Exchange and the investing public of the retirement of Pharm Matthew Obi Azoji as Managing Director/ CEO of the Company. Presently, he has embarked on 3 months terminal leave. His retirement is effective 5th June 2023.

Notice is also given of the appointment of Pharm. Gerald Ijeoma Oputa as acting Managing Director/CEO of the Company effective from 6th of March 2023, pending the appointment of a substantive Managing Director/CEO.

Pharm. Gerald Ijeoma Oputa is currently the Executive Director of Sales & Marketing of Neimeth International Pharmaceuticals Plc. He joined the Company on 1st of April 2022.

Leave a Reply

Your email address will not be published. Required fields are marked *